User: flenvcenter Topic: Environmental Health-National
Category: Biotech
Last updated: Nov 08 2017 07:07 IST RSS 2.0
 
1 to 20 of 6,505    
GMO apples heading to Midwest supermarkets 8.11.2017 SFGate: Business & Technology
Genetically modified fruit salad just got real. Along with virus-resistant papayas, apples are joining the ranks of biotech fruit sold in U.S. grocery stores. The first commercial harvest of GMO golden delicious apples will be going from Washington state orchards to 400 Midwestern grocery stores this month. They will be sliced up and sold in 10-ounce bags, and because they’re modified, they take much longer to brown when exposed to the air. While GMO crops are the mainstream for U.S. commodities like corn and soybeans, that isn’t the case with fruits.
Also found in: [+]
Biotech company gets funding for work to illuminate cancers 4.11.2017 Science / Technology News

Illumination can enable surgeons to see and remove cancer lesions they otherwise might have missed. WEST LAFAYETTE, Ind.

Also found in: [+]
'Modified' asks why Canada and U.S. refuse to label genetically modified foods 27.10.2017 TreeHugger
But more than that, the film is a love story about cooking and gardening -- and the importance of regaining control over where our food comes from.
Also found in: [+]
Milk, salads, kitty litter, condoms: 'Non-GMO' labels sow confusion 25.10.2017 LA Times: Commentary

Clover Sonoma dairy has long cultivated a dual image of folksy kitsch and foodie trend-spotting.

While its cartoon mascot, Clo the Cow, cracked tortured puns on billboards along U.S. 101, the Bay Area’s top milk supplier touted its small-scale farms in the dwindling grasslands of California’s northern...

Also found in: [+]
Amid GMO strife, food industry vies for public trust in CRISPR technology 25.10.2017 Minnesota Public Radio: Law & Justice
Mushrooms that don't brown? Pigs resistant to diseases? Though the process does not introduce foreign genetic material into food or livestock, getting consumers to buy in will be an uphill battle.
Also found in: [+]
Amid GMO Strife, Food Industry Vies For Public Trust In CRISPR Technology 25.10.2017 NPR News
Mushrooms that don't brown? Pigs resistant to diseases? Though the process does not introduce foreign genetic material into food or livestock, getting consumers to buy in will be an uphill battle.
Also found in: [+]
Exposure to Glyphosate, Chemical Found in Weed Killers, Increased Over 23 Years 24.10.2017 Environmental News Network
Analyzing samples from a prospective study, University of California San Diego School of Medicine researchers found that human exposure to glyphosate, a chemical widely found in weed killers, has increased approximately 500 percent since the introduction of genetically modified crops.
Also found in: [+]
CRISPR bacon: Chinese scientists create genetically modified low-fat pigs 24.10.2017 Minnesota Public Radio: Law & Justice
Scientists have used CRISPR, a new gene-editing technique, to create pigs that can keep their bodies warmer, burning more fat to produce leaner meat.
Also found in: [+]
Can Science Change The Mildewed Fortunes Of New York Heritage Hops? 24.10.2017 NPR Health Science
Hops helped make vast fortunes for 19th century farmers and brewers in New York state before a mildew blight ushered in their demise. Now, undergrads hope to develop mildew-resistant heritage hops.
Also found in: [+]
CRISPR Bacon: Chinese Scientists Create Genetically Modified Low-Fat Pigs 24.10.2017 NPR Health Science
Scientists have used CRISPR, a new gene-editing technique, to create pigs that can keep their bodies warmer, burning more fat to produce leaner meat.
Also found in: [+]
Getting behind the debate over lab-grown meat 17.10.2017 Business Operations | GreenBiz.com
The dialogue over human health, equity and the sustainable future of our food system is just beginning.
Also found in: [+]
A biotech breakthrough hopes to save bananas from extinction 16.10.2017 TreeHugger
While banana farmers watch their plantations get ravaged by a fungal disease, scientists think they may have found a solution.
Also found in: [+]
Rep. Chris Collins’s advocacy for biotech company broke rules, House ethics watchdog finds 13.10.2017 Washington Post: Politics
The New York Republican recruited investors that included family, his congressional staff and House colleagues.
Also found in: [+]
Have Monsanto and the Biotech Industry Turned Natural Bt Pesticides Into GMO "Super Toxins"? 11.10.2017 Truthout - All Articles
In times of great injustice, independent media is crucial to fighting back against misinformation. Support grassroots journalism: Make a donation to Truthout by clicking here. Is the supposed safety advantage of GMO crops over conventional chemical pesticides a mirage? According to biotech lore, the Bt pesticides introduced into many GMO food crops are natural proteins whose toxic activity extends  only to narrow groups of insect species . Therefore, says the industry, these pesticides can all be safely eaten, e.g. by humans. This is not the interpretation we arrived at after our analysis of the documents accompanying the commercial approval of 23 typical Bt-containing GMO crops, however (see  Latham et al., 2017 , just published in the journal Biotechnology and Genetic Engineering Reviews). In our publication, authored along with Madeleine Love and Angelika Hilbeck, of the Swiss Federal Institute of Technology (ETH), we show that commercial GMO Bt toxins differ greatly from their natural precursors. ...
Also found in: [+]
Tentative settlement reached in genetically modified seed case 26.9.2017 Minnesota Public Radio: Law & Justice
A major agricultural seed company has reached a pending settlement with U.S. farmers including thousands from Minnesota in a case involving a genetically modified corn seed.
Also found in: [+]
FDA clears cheaper biotech drug copycats, but buying them isn’t easy 20.9.2017 SFGate: Business & Technology
In 2016, Roche sold $3 billion worth of its blockbuster biotechnology drug Avastin. Last week, the Food and Drug Administration approved what’s expected to be a less-expensive version. Patients and insurers won’t be able to count the savings any time soon. Of seven biosimilar drugs the FDA has cleared since the first approval of one of the drugs in 2015, only three are available for sale. The rest are tied up in legal disputes that can block the cheaper versions for years. “Basically, there’s a gazillion patents,” said Gillian Woollett, senior vice president at the consulting firm Avalere Health and an expert on the drugs.
Also found in: [+]
Scientists Try To Fight Crop Damage With An Invasive Moth's Own DNA 28.8.2017 NPR News
The diamondback moth attacks cabbage, broccoli and cauliflower, costing farmers billions of dollars every year. But will these lab-bred insects inherit the same stigma as genetically modified crops?
Also found in: [+]
Gilead is buying Santa Monica biotech firm Kite Pharma for $11.9 billion 28.8.2017 LA Times: Business

Santa Monica biotech firm Kite Pharma Inc., which specializes in cancer-fighting treatments, is being acquired by industry giant Gilead Sciences Inc. for $11.9 billion, the companies announced Monday.

Kite Pharma has a cell therapy treatment for non-Hodgkin’s lymphoma under review by the Food and...

Also found in: [+]
NantHealth to cut 300 employees, will sell some assets to Allscripts 12.8.2017 LA Times: Business

Los Angeles billionaire Patrick Soon-Shiong’s NantHealth Inc. said it would cut about 300 employees and sell some assets as the biotech company looks to focus on artificial intelligence for cancer treatment.

The Culver City company said Thursday that it signed an agreement to sell its provider...

Also found in: [+]
'Path to GMO humans' presents 'profound ethical issues' 9.8.2017 LA Times: Commentary

To the editor: As pointed out in your editorial, the ethics related to gene editing are extremely complicated. This is especially true in today’s pragmatic culture. (Re “The path to GMO humans,” Editorial, Aug. 4)

All so-called improvements are not good. Although much good can come out of gene...

Also found in: [+]
1 to 20 of 6,505